ticlopidine has been researched along with Sickle Cell Trait in 1 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
Sickle Cell Trait: The condition of being heterozygous for hemoglobin S.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sablayrolles, M | 1 |
| Wajcman, H | 1 |
| Castaigne, JP | 1 |
| Labie, D | 1 |
1 other study available for ticlopidine and Sickle Cell Trait
| Article | Year |
|---|---|
Membrane expansion as a mechanism explaining the antisickling action of ticlopidine observed in vitro.
Topics: Anemia, Sickle Cell; Antisickling Agents; Densitometry; Erythrocyte Membrane; Humans; Kinetics; Osmo | 1985 |